<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.13195.005</object-id><label>Table 1.</label><caption><p>Antimicrobial drug usage in the study population.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.13195.005">http://dx.doi.org/10.7554/eLife.13195.005</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Drug (dosage)</th><th valign="bottom">Drug Class</th><th valign="top">Primary Reason for Use</th><th colspan="8" valign="bottom">Number of Animals treated (<italic>%</italic>)</th></tr></thead><tbody><tr><td valign="bottom"/><td valign="bottom"/><td valign="top"/><td valign="bottom">Pen A</td><td valign="top">Pen B</td><td valign="top">Pen C</td><td valign="top">Pen D</td><td valign="top">Pen E</td><td valign="top">Pen F</td><td valign="top">Pen G</td><td valign="top">Pen H</td></tr><tr><td>Tylosin phosphate <break/>(11 mg/kg diet dry matter)<sup>a</sup></td><td>Macrolide</td><td valign="top">Liver abscess prevention</td><td>244 <break/>(100)</td><td>281 <break/>(100)</td><td>152 <break/>(100)</td><td>189 <break/>(100)</td><td>230 <break/>(100)</td><td>230 <break/>(100)</td><td>265 <break/>(100)</td><td>150 <break/>()</td></tr><tr><td>Tulathromycin<sup>b</sup> <break/>(2.5 mg/kg BW<sup>c</sup>)</td><td>Macrolide</td><td valign="top">BRD<sup>d</sup> Treatment</td><td>15 <break/>(6.1)</td><td>16 <break/>(5.7)</td><td>12 <break/>(7.9)</td><td>3 <break/>(1.6)</td><td>19 <break/>(8.3)</td><td>3 <break/>(1.3)</td><td>8 <break/>(3.0)</td><td>5 <break/>(3.3)</td></tr><tr><td>Oxytetracycline<sup>e</sup> <break/>(20 mg/kg BW)</td><td>Tetracycline</td><td valign="top">BRD Treatment</td><td>1 <break/>(0.4)</td><td>1 <break/>(0.4)</td><td>43 <break/>(28.3)</td><td>9 <break/>(4.8)</td><td>6 <break/>(2.6)</td><td>2 <break/>(0.9)</td><td>13 <break/>(4.9)</td><td>10 <break/>(6.7)</td></tr><tr><td>Oxytetracycline and Flunixin meglumine<sup>b</sup> <break/>(30 mg/kg BW and 2 mg/kg BW)</td><td>Tetracycline</td><td valign="top">BRD Treatment</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>1 <break/>(0.4)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td></tr><tr><td>Danofloxacin mesylate<sup>b</sup> <break/>(8 mg/kg BW)</td><td>Fluoroquinolone</td><td valign="top">BRD Treatment</td><td>0 <break/>(0.0)</td><td>4 <break/>(1.4)</td><td>1 <break/>(0.7)</td><td>0 <break/>(0.0)</td><td>4 <break/>(1.7)</td><td>7 <break/>(3.0)</td><td>2 <break/>(0.8)</td><td>0 <break/>(0.0)</td></tr><tr><td>Enrofloxacin<sup>b</sup> <break/>(7.7 mg/kg BW)</td><td>Fluoroquinolone</td><td valign="top">BRD Treatment</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>2 <break/>(0.8)</td><td>0 <break/>(0.0)</td></tr><tr><td>Ceftiofur sodium<sup>e</sup> <break/>(1 mg/kg BW)</td><td>&#946;-lactam</td><td valign="top">BRD Treatment</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>2 <break/>(1.3)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td></tr><tr><td>Ceftiofur crystalline free acid<sup>b</sup> <break/>(6.6 mg/kg BW)</td><td>&#946;-lactam</td><td valign="top">BRD Treatment</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>0 <break/>(0.0)</td><td>4 <break/>(1.5)</td><td>1 <break/>(0.7)</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p><sup>a</sup>This AMD was in all rations of all cattle for the duration of the feeding period</p></fn><fn id="tblfn2"><p><sup>b</sup>Each treated animal received a dose that persisted in target tissues at effective therapeutic concentrations for 3 days, according to the drug label.</p></fn><fn id="tblfn3"><p><sup>c</sup>BW = body weight</p></fn><fn id="tblfn4"><p><sup>d</sup>BRD = bovine respiratory disease</p></fn><fn id="tblfn5"><p><sup>e</sup>Each treated animal received a dose that persisted in target tissues at effective therapeutic concentrations for 1 day, according to the drug label.</p></fn></table-wrap-foot></table-wrap>